These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20621419)

  • 1. Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects.
    Eisenberg E; Midbari A; Haddad M; Pud D
    Pain; 2010 Oct; 151(1):104-109. PubMed ID: 20621419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug efficacy in chronic low back pain by quantitative sensory tests.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Stamer U; Arendt-Nielsen L; Curatolo M
    Eur J Pain; 2018 May; 22(5):973-988. PubMed ID: 29363217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxycodone alters temporal summation but not conditioned pain modulation: preclinical findings and possible relations to mechanisms of opioid analgesia.
    Suzan E; Midbari A; Treister R; Haddad M; Pud D; Eisenberg E
    Pain; 2013 Aug; 154(8):1413-8. PubMed ID: 23707271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Arendt-Nielsen L; Curatolo M
    Scand J Pain; 2017 Oct; 17():107-115. PubMed ID: 28850362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study.
    Olesen AE; Staahl C; Arendt-Nielsen L; Drewes AM
    Br J Clin Pharmacol; 2010 Aug; 70(2):189-200. PubMed ID: 20653672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can quantitative sensory testing predict responses to analgesic treatment?
    Grosen K; Fischer IW; Olesen AE; Drewes AM
    Eur J Pain; 2013 Oct; 17(9):1267-80. PubMed ID: 23658120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers.
    Cooper ZD; Johnson KW; Vosburg SK; Sullivan MA; Manubay J; Martinez D; Jones JD; Saccone PA; Comer SD
    Drug Alcohol Depend; 2017 Sep; 178():340-347. PubMed ID: 28688296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism.
    Zwisler ST; Enggaard TP; Noehr-Jensen L; Pedersen RS; Mikkelsen S; Nielsen F; Brosen K; Sindrup SH
    Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):335-44. PubMed ID: 19281600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased pain sensitivity in chronic pain subjects on opioid therapy: a cross-sectional study using quantitative sensory testing.
    Zhang Y; Ahmed S; Vo T; St Hilaire K; Houghton M; Cohen AS; Mao J; Chen L
    Pain Med; 2015 May; 16(5):911-22. PubMed ID: 25376890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of static and dynamic quantitative sensory testing in patients with painful chronic pancreatitis.
    Olesen SS; van Goor H; Bouwense SA; Wilder-Smith OH; Drewes AM
    Reg Anesth Pain Med; 2012; 37(5):530-6. PubMed ID: 22854397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.
    Siegenthaler A; Schliessbach J; Vuilleumier PH; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    BMC Pharmacol Toxicol; 2015 Sep; 16():23. PubMed ID: 26376691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans.
    Babalonis S; Lofwall MR; Sloan PA; Nuzzo PA; Fanucchi LC; Walsh SL
    Psychopharmacology (Berl); 2019 Nov; 236(11):3341-3352. PubMed ID: 31201479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study.
    Staahl C; Dimcevski G; Andersen SD; Thorsgaard N; Christrup LL; Arendt-Nielsen L; Drewes AM
    Scand J Gastroenterol; 2007 Mar; 42(3):383-90. PubMed ID: 17354119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain.
    Arendt-Nielsen L; Olesen AE; Staahl C; Menzaghi F; Kell S; Wong GY; Drewes AM
    Anesthesiology; 2009 Sep; 111(3):616-24. PubMed ID: 19672186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
    Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
    J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term reliability of static and dynamic quantitative sensory testing in healthy individuals.
    Marcuzzi A; Wrigley PJ; Dean CM; Adams R; Hush JM
    Pain; 2017 Jul; 158(7):1217-1223. PubMed ID: 28328574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic and pharmacodynamic study of oral oxycodone in a human experimental pain model of hyperalgesia.
    Olesen AE; Upton R; Foster DJ; Staahl C; Christrup LL; Arendt-Nielsen L; Drewes AM
    Clin Pharmacokinet; 2010 Dec; 49(12):817-27. PubMed ID: 20873879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population pharmacokinetic and pharmacodynamic study of a peripheral κ-opioid receptor agonist CR665 and oxycodone.
    Olesen AE; Kristensen K; Staahl C; Kell S; Wong GY; Arendt-Nielsen L; Drewes AM
    Clin Pharmacokinet; 2013 Feb; 52(2):125-37. PubMed ID: 23212610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.
    Cooper ZD; Bedi G; Ramesh D; Balter R; Comer SD; Haney M
    Neuropsychopharmacology; 2018 Sep; 43(10):2046-2055. PubMed ID: 29463913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic influences on oxycodone response characteristics in human experimental pain.
    Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J
    Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.